Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- VBIV
- Price
- -
- Stock movement down
- -0.04 (-56.81%)
- Company name
- VBI Vaccines Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 808.84K
- Ent value
- 69.12M
- Price/Sales
- 0.09
- Price/Book
- 0.11
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -27.16%
- 1 year return
- -97.78%
- 3 year return
- -93.34%
- 5 year return
- -73.20%
- 10 year return
- -61.40%
Last updated: 2024-12-17
DIVIDENDS
VBIV does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.09 |
| Price to Book | 0.11 |
| EV to Sales | 7.64 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 28.68M |
| EPS (TTM) | -2.72 |
| FCF per share (TTM) | -2.13 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 9.05M |
| Gross profit (TTM) | -3.32M |
| Operating income (TTM) | -71.77M |
| Net income (TTM) | -65.10M |
| EPS (TTM) | -2.72 |
| EPS (1y forward) | -0.28 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -36.66% |
| Operating margin (TTM) | -793.03% |
| Profit margin (TTM) | -719.31% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.60M |
| Net receivables | 1.74M |
| Total current assets | 26.36M |
| Goodwill | 1.11M |
| Intangible assets | 35.73M |
| Property, plant and equipment | 11.04M |
| Total assets | 75.44M |
| Accounts payable | 8.87M |
| Short/Current long term debt | 50.71M |
| Total current liabilities | 77.59M |
| Total liabilities | 80.91M |
| Shareholder's equity | 7.53M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -50.53M |
| Capital expenditures (TTM) | 492.22K |
| Free cash flow (TTM) | -51.02M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -864.86% |
| Return on Assets | -74.87% |
| Return on Invested Capital | -109.83% |
| Cash Return on Invested Capital | -86.08% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| VBIV | S&P500 | |
| Current price drop from All-time high | -100.00% | -6.06% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 8 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -80.90% | -10.99% |
| Avg time to new high | 66 days | 12 days |
| Max time to new high | 3229 days | 1805 days |
COMPANY DETAILS
Marketcap
808.84K
Marketcap category
Small-cap
Description
VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
Employees
131
Website
Investor relations
-
SEC filings
CEO
Jeffrey R. Baxter
Country
USA
City
Cambridge
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner